Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment.

× No keyword cloud information.

61 in total

1. Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis.

Authors: Alessia Fornoni; Junichiro Sageshima; Changli Wei; Sandra Merscher-Gomez; Robier Aguillon-Prada; Alexandra N Jauregui; Jing Li; Adela Mattiazzi; Gaetano Ciancio; Linda Chen; Gaston Zilleruelo; Carolyn Abitbol; Jayanthi Chandar; Wacheree Seeherunvong; Camillo Ricordi; Masami Ikehata; Maria Pia Rastaldi; Jochen Reiser; George W Burke
Journal: Sci Transl Med Date: 2011-06-01 Impact factor: 17.956

2. Busy Bs.

Authors: Howard Trachtman
Journal: J Am Soc Nephrol Date: 2015-11-30 Impact factor: 10.121

3. Refractory focal segmental glomerulosclerosis in the adult: complete and sustained remissions of two episodes of nephrotic syndrome after a single dose of rituximab.

Authors: Maddalena Marasà; Paolo Cravedi; Barbara Ruggiero; Piero Ruggenenti
Journal: BMJ Case Rep Date: 2014-08-25

4. Does rituximab treat recurrent focal segmental glomerulosclerosis post-renal transplantation?

Authors: Stephen D Marks; Mary McGraw
Journal: Pediatr Nephrol Date: 2006-08-26 Impact factor: 3.714

5. Fatal pulmonary fibrosis after rituximab administration.

Authors: Marie-Camille Chaumais; Arnaud Garnier; François Chalard; Michel Peuchmaur; Stephane Dauger; Evelyne Jacqz-Agrain; Georges Deschênes
Journal: Pediatr Nephrol Date: 2009-04-25 Impact factor: 3.714

Review 6. Nanosized contrast agents to noninvasively detect kidney inflammation by magnetic resonance imaging.

Authors: Joshua M Thurman; Natalie J Serkova
Journal: Adv Chronic Kidney Dis Date: 2013-11 Impact factor: 3.620

7. Rituximab and Therapeutic Plasma Exchange in Recurrent Focal Segmental Glomerulosclerosis Postkidney Transplantation.

Authors: Sami Alasfar; Dany Matar; Robert A Montgomery; Niraj Desai; Bonnie Lonze; Vikas Vujjini; Michelle M Estrella; John Manllo Dieck; Gebran Khneizer; Sanja Sever; Jochen Reiser; Nada Alachkar
Journal: Transplantation Date: 2018-03 Impact factor: 4.939

8. Rituximab treatment prevents the early development of proteinuria following pig-to-baboon xeno-kidney transplantation.

Authors: Masayuki Tasaki; Akira Shimizu; Isabel Hanekamp; Radbeh Torabi; Vincenzo Villani; Kazuhiko Yamada
Journal: J Am Soc Nephrol Date: 2014-01-23 Impact factor: 10.121

Review 9. The role of the immune system in idiopathic nephrotic syndrome: a review of clinical and experimental studies.

Authors: Wagner de Fátima Pereira; Gustavo Eustáquio Alvim Brito-Melo; Fábio Tadeu Lourenço Guimarães; Thiago Guimarães Rosa Carvalho; Elvis Cueva Mateo; Ana Cristina Simões e Silva
Journal: Inflamm Res Date: 2014-01 Impact factor: 4.575

10. Efficacy of rituximab therapy in children with refractory nephrotic syndrome: a prospective observational study in Shanghai.

Authors: Li Sun; Hong Xu; Qian Shen; Qi Cao; Jia Rao; Hai-Mei Liu; Xiao-Yan Fang; Li-Jun Zhou
Journal: World J Pediatr Date: 2014-01-25 Impact factor: 2.764